TickrTrends NOVT fair value analysis

Novanta to Present at Baird Global Healthcare Conference on Tuesday, September 15, 2026

financialpost.com · 2026-08-28

BOSTON — Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that…

TickrTrends take: Novanta's presentation at the Baird Global Healthcare Conference provides an opportunity for investors to hear directly from management about the company's strategic direction and operational performance in the technology sector. Given TickrTrends' current assessment that NOVT is undervalued, this conference appearance could serve as a catalyst for the market to reassess the company's growth prospects and competitive positioning. Valuation-focused readers should monitor whether management commentary during the presentation addresses profitability drivers, market expansion opportunities, or operational efficiency improvements that might justify a revaluation upward from current levels.

Read the full story at financialpost.com →

Is NOVT undervalued? See TickrTrends' fair value analysis →